GlassScriptPhysician profile
Jeffrey Tyler
NPI 1588082820
$411,116.03
in general payments reported to CMS, 2019-2025
43 companies · $100K in 2025
The $100K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $17K · 2021: $5,933 · 2022: $53K · 2023: $108K · 2024: $127K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $85K · Consulting Fee: $84K · Honoraria: $66K · Travel and Lodging: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Food and Beverage: $21K · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $84,925.00 |
| Consulting Fee | $83,672.50 |
| Honoraria | $66,350.00 |
| Travel and Lodging | $43,838.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,008.75 |
| Food and Beverage | $20,509.67 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $167,159.36 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $105,002.66 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $25,026.87 | 2020-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $22,183.93 | 2021-2025 | Diamondback Coronary, Mitraclip, Optis |
| Cardiovascular Systems INC. | $19,644.83 | 2020-2023 | Diamondback Coronary, Diamondback Peripheral |
| Lilly USA, LLC | $17,632.07 | 2024-2025 | Jardiance, Mounjaro |
| Atricure, INC. | $16,423.65 | 2022-2025 | Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $15,185.59 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,719.53 | 2022-2025 | Jardiance |
| Penumbra, INC. | $2,540.95 | 2021-2025 | Indigo System |
| Boston Scientific Corporation | $2,482.75 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Baylis Medical Company Radiofrequency Puncture Generator |
| W. L. Gore & Associates, INC. | $1,859.50 | 2024 | Gore Cardioform Septal Occluder |
| Medtronic, INC. | $1,683.41 | 2021-2025 | Corevalve Evolut R |
| Amgen INC. | $639.14 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $618.62 | 2021-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $277.42 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $266.62 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $258.37 | 2024-2025 | Camzyos, Eliquis |
| Philips North America LLC | $253.27 | 2021-2024 | (P84) Igt Devices Systems |
| Astrazeneca Pharmaceuticals LP | $245.28 | 2021-2024 | Wainua |
| Merck Sharp & Dohme LLC | $228.74 | 2022-2025 | Winrevair, Verquvo, Capvaxive |
| Biotronik INC. | $227.12 | 2021 | |
| Saranas, INC. | $167.01 | 2023 | |
| Astellas Pharma US INC | $163.98 | 2022 | |
| Pfizer INC. | $138.73 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $125.00 | 2025 | Amvuttra |
| Avinger INC. | $124.25 | 2021 | |
| Bridgebio Pharma, INC. | $116.25 | 2025 | Attruby |
| Scpharmaceuticals INC. | $104.50 | 2023-2025 | |
| Cordis US Corp. | $103.94 | 2025 | Mynx Control Venous |
| Cardiva Medical, INC. | $98.21 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Baxter Healthcare | $61.75 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $58.33 | 2022-2024 | |
| Glaxosmithkline, LLC. | $56.16 | 2022 | |
| Recor Medical INC | $46.72 | 2025 | Paradise Ultrasound Renal Denervation System |
| Siemens Medical Solutions USA, INC. | $44.43 | 2022 | |
| Kestra Medical Technology Services, INC. | $42.97 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $24.69 | 2023 | R2p Misago |
| Novo Nordisk INC | $17.61 | 2024 | Ozempic |
| Irhythm Technologies, INC. | $17.55 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $17.35 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.99 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Tyler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.